Reata Pharmaceuticals Inc

CITADEL ADVISORS LLC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

571,529

Value ($000)

58,273

Weight

0.1%

2019 Q4 - 2023 Q2 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	58,273	0.1%	571,529	6/30/2023
2023 Q1	5/15/2023	2,928	0.0%	32,207	3/31/2023
2022 Q4	2/14/2023	2,835	0.0%	74,636	12/31/2022
2022 Q3	11/14/2022	4,066	0.0%	161,815	9/30/2022
2022 Q2	8/15/2022	6,944	0.0%	228,503	6/30/2022
2022 Q1	5/16/2022	4,220	0.0%	128,843	3/31/2022
2021 Q4	2/14/2022	1,594	0.0%	60,421	12/31/2021
2021 Q3	11/15/2021	623	0.0%	6,193	9/30/2021
2021 Q1	5/21/2021	2,116	0.0%	21,229	3/31/2021
2020 Q4	2/16/2021	2,906	0.0%	23,503	12/31/2020
2020 Q3	11/16/2020	3,300	0.0%	33,872	9/30/2020
2020 Q2	8/14/2020	8,391	0.0%	53,780	6/30/2020
2020 Q1	5/15/2020	10,958	0.0%	75,921	3/31/2020
2019 Q4	2/14/2020	6,945	0.0%	33,970	12/31/2019